On March 9, 2026, a high‑level delegation from the U.S. Pharmacopeia (USP) visited Milestone Pharma. The delegation was led by Amanda Cowley, USP SVP and Chief Growth Officer, and Dr. Cen Guoshan, USP VP and China General Manager. Together with Milestone Pharma’s core team, the two sides engaged in in‑depth strategic discussions on pharmacopeial standards application, tackling complex drug technologies, and future strategic collaboration directions – jointly promoting the harmonized development of global pharmaceutical quality standards.
Dec 04, 2025
Dec 14, 2023
Aug 08, 2023